ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002GlobeNewsWire · Oct 12, 2026
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)GlobeNewsWire · Oct 1, 2026
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026PRNewsWire · Oct 1, 2026The BlackRock MuniHoldings California Quality Fund, Inc. (MUC) is a closed-end investment vehicle initially brought to market by BlackRock, Inc. Its day-to-day management falls under the purview of BlackRock Advisors, LLC. This fund primarily allocates capital within the fixed-income sector, focusing predominantly on a portfolio of high-quality, long-term municipal debt instruments.